GOUT INDUCED BY L-DOPA AND DECARBOXYLASE INHIBITORS

被引：9
|
作者：
CALNE, DB
FERMAGLICH, J
机构：
[1] NINCDS,DEPT HEW,BETHESDA,MD 20014
[2] GEORGETOWN UNIV HOSP,DEPT NEUROL,WASHINGTON,DC 20007
来源：
POSTGRADUATE MEDICAL JOURNAL | 1976年 / 52卷 / 606期
关键词：
D O I：
10.1136/pgmj.52.606.232
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：232 / 233
页数：2
相关论文
共 50 条
  • [41] COMBINED TREATMENT OF PARKINSONS-DISEASE WITH L-DOPA PLUS DECARBOXYLASE INHIBITORS (CARBIDOPA, BENSERAZIDE)
    PODIWINSKY, F
    MENTASTI, M
    RIEDERER, P
    BIRKMAYER, W
    WIENER KLINISCHE WOCHENSCHRIFT, 1979, 91 (10) : 332 - 337
  • [42] TREATMENT OF SYDENHAMS CHOREA WITH A COMBINATION OF L-DOPA AND A PERIPHERAL DOPA DECARBOXYLASE INHIBITOR
    SPISSU, A
    CORSINI, GU
    MARROSU, F
    MANGONI, A
    GESSA, GL
    PSYCHOPHARMACOLOGIA, 1975, 44 (03): : 311 - 312
  • [43] TREATMENT OF PARKINSONISM BY L-DOPA AND DOPA-DECARBOXYLASE INHIBITOR IN A SINGLE TABLET
    SAROVAPI.I
    BRAHAM, J
    HAREFUAH, 1974, 87 (05) : 208 - 210
  • [44] MEASURING L-DOPA IN PLASMA AND URINE TO MONITOR THERAPY OF ELDERLY PATIENTS WITH PARKINSON DISEASE TREATED WITH L-DOPA AND A DOPA DECARBOXYLASE INHIBITOR
    DUTTON, J
    COPELAND, LG
    PLAYFER, JR
    ROBERTS, NB
    CLINICAL CHEMISTRY, 1993, 39 (04) : 629 - 634
  • [45] Evidence for L-Dopa Decarboxylase Involvement in Cancer Cell Cytotoxicity Induced by Docetaxel and Mitoxantrone
    Kalantzis, Evangelos D.
    Scorilas, Andreas
    Vassilacopoulou, Dido
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2018, 19 (13) : 1087 - 1096
  • [46] L-DOPA INDUCED CHANGES IN CENTRAL MONOAMINE NEURONS AFTER PERIPHERAL DECARBOXYLASE INHIBITION
    BUTCHER, L
    ENGEL, J
    FUXE, K
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 1970, 22 (04) : 313 - +
  • [47] L-Dopa induced dyskinesias in Parkinsonian mice: Disease severity or L-Dopa history
    Shan, Lufei
    Diaz, Oscar
    Zhang, Yajun
    Ladenheim, Bruce
    Cadet, Jean-Lud
    Chiang, Yung-Hsiao
    Olson, Lars
    Hoffer, Barry J.
    Baeckman, Cristina M.
    BRAIN RESEARCH, 2015, 1618 : 261 - 269
  • [48] COMBINED THERAPY OF PARKINSONISM WITH BROMOCRIPTINE, L-DOPA AND DECARBOXYLASE INHIBITOR
    VARDY, J
    RABEY, JM
    STREIFLER, M
    HAREFUAH, 1977, 93 (5-6) : 129 - 133
  • [49] ON THE RELATION BETWEEN L-DOPA DECARBOXYLASE AND ZN2+
    SHIBATA, Y
    OHTA, T
    NAKATSUKA, M
    MATSUDA, Y
    SHINDO, T
    TSUBOUCHI, R
    YOSHINO, M
    HIRANO, S
    NOGUCHI, T
    JOURNAL OF NEUROCHEMISTRY, 1995, 65 : S184 - S184
  • [50] Emerging Role of l-Dopa Decarboxylase in Flaviviridae Virus Infections
    Frakolaki, Efseveia
    Kalliampakou, Katerina, I
    Kaimou, Panagiota
    Moraiti, Maria
    Kolaitis, Nikolaus
    Boleti, Haralabia
    Koskinas, John
    Vassilacopoulou, Dido
    Vassilaki, Niki
    CELLS, 2019, 8 (08)
12345